Vertex Pharmaceuticals, Inc. (VRTX)
425.98
-4.31
(-1.00%)
USD |
NASDAQ |
Apr 27, 16:00
425.98
0.00 (0.00%)
After-Hours: 18:16
Vertex Pharmaceuticals Market Cap : 108.21B for April 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 158.57B |
| Eli Lilly & Co. | 776.23B |
| Amgen, Inc. | 183.36B |
| Moderna, Inc. | 19.31B |
| Regeneron Pharmaceuticals, Inc. | 78.71B |
Market Cap Related Metrics
| PE Ratio | 27.78 |
| PS Ratio | 9.103 |
| Price to Book Value | 5.797 |
| Price to Free Cash Flow | 34.41 |
| Price | 425.98 |
| Earnings Yield | 3.60% |
| Operating PE Ratio | 23.18 |
| Normalized PE Ratio | 25.40 |